ClinicalTrials.Veeva

Menu

PRecIsion Medicine in CardiomyopathY (PRIMaCY)

T

The Hospital for Sick Children

Status

Active, not recruiting

Conditions

Sudden Cardiac Death
Hypertrophic Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT04036799
1000055819

Details and patient eligibility

About

This is a retrospective cohort study of pediatric hypertrophic cardiomyopathy (HCM) patients using chart and registry review methodology. The studies objective is to develop and validate a sudden cardiac death (SCD) risk calculator that is age-appropriate for children with HCM that includes clinical and genetic factors.

Enrollment

572 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • phenotype-positive patients diagnosed with hypertrophic cardiomyopathy
  • phenotype-negative, genotype positive patients considered at risk for developing hypertrophic cardiomyopathy

Exclusion criteria

  • Neuromuscular, metabolic, syndromic (other than Noonan Syndrome and related RAS-opathies) or endocrine (including infants of diabetic mothers) causes of HCM
  • (Other treatable causes of left ventricular hypertrophy (systemic hypertension, anatomic defects causing left ventricular outflow tract obstruction e.g. aortic stenosis, subAS, subaortic membrane, coarctation)

Trial design

572 participants in 1 patient group

Hypertrophic Cardiomyopathy

Trial documents
2

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems